Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Abiomed Inc (NQ: ABMD )

311.94 USD UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Jan 24, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 311.94
Bid (Size) 270.00 (1)
Ask (Size) 370.00 (1)
Prev. Close 311.94
Today's Range 311.94 - 311.94
52wk Range 261.27 - 387.40
Shares Outstanding 45,497,490
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Abiomed Third Quarter Fiscal 2022 Earnings and Conference Call Notification
Abiomed announces that on Thursday, February 3, 2022, the Company will release financial results for the third quarter of the fiscal year 2022. 
From Business Wire News Releases
Early Feasibility Study Demonstrates Successful Use of Abiomed’s preCARDIA Technology
Abiomed announces the successful results of the first-in-human early feasibility study of the preCARDIA system. 
From Business Wire News Releases

Performance

YTD
-14.84%
-14.84%
1 Month
-12.82%
-12.82%
3 Month
-11.89%
-11.89%
6 Month
-4.02%
-4.02%
1 Year
-10.44%
-10.44%

More News

Read More
Regulators Approve Impella 5.5 With SmartAssist in Japan and Hong Kong; US FDA Grants Impella BTR Conditional IDE Approval for First-in-Human Early Feasibility Study
From Business Wire News Releases
Abiomed to Present at the 40th Annual J.P. Morgan Healthcare Conference
From Business Wire News Releases
10 Health Care Stocks Whale Activity In Today's Session
Tags IONS PFE ZTS
From Benzinga
Abiomed to Present at Upcoming Investor Conferences
From Business Wire News Releases
RSP, CERN, CTXS, ABMD: ETF Inflow Alert
Tags ETFs
From ETF Channel
Two Large Studies Demonstrate Complete Revascularization with Impella Heart Pumps Improves Ejection Fraction and Long-Term Patient Outcomes
From Business Wire News Releases
Impella Advances to Higher Level of Recommendation in Newest ESC Guidelines
From Business Wire News Releases
12 Health Care Stocks Moving In Monday's After-Market Session
Tags PETV ABMD RMTI
From Benzinga
TCT 2021 to Highlight Improved Patient Outcomes with Impella’s Small, Smart and Connected Technology
From Business Wire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.